News

Another year, another survivors' day.

New resource provides mechanism for viewing a hospital's billing track record.

Goal of proposed law is to improve patient care and reduce the nursing shortage.

A problem for many people undergoing cancer treatment.

Few baby boomers are facing the facts about aging.

USPSTF is inviting comments on screening by primary care professionals.

Melanoma is on the rise in children and teenagers.

The number of cancer survivors in the US continues to rise.

RNs with baccalaureate degrees provide the best post-surgical care.

A money-losing proposition for most practices.

Using different selection criteria for screening is superior to currently recommended criteria.

A consensus panel issues a set of discharge warning instructions regarding colorectal surgery.

The FDA has announced the approval of the first generic version of Doxil, which is expected to help alleviate a shortage of the drug that has continued since November 2011.

For the first time, Consumer Reports issues ratings of cancer screening tests.

An effective alternative to mastectomy for early stage disease regardless of age or hormone receptor status.

Screening rates are lower than desired, and disparities continue.

A pair of studies could change the way patients are evaluated for mutations of BRCA1 and BRCA2, two cancer susceptibility genes closely associated with breast and ovarian cancers, as well as other tumor types.

The FDA approved 11 new hematology-oncology drugs in 2012.

ASCO issues recommendations for improving cancer survivorship care.

Surprising findings about tumor board effectiveness in the VA system.

Nurses again rank highest in Gallup's survey on honesty and ethical standards.

Of the 10 most lethal cancers, it's the only one with a single digit survival rate.

Updated Cochrane review supports the benefits of aerobic exercise.

Since last year, there has been significant improvement in career satisfaction.

YouTube video provides guidance on assessing for skin cancer.

National summit convened to reduce overuse of unnecessary procedures and treatments.

Does "think pink" actually raise awareness of breast cancer?

Study finds that stability beyond the expiration date is surprisingly long-term.

There now are many phone-based "self-help" tools.

In April 2010, the FDA approved sipuleucel-T for patients with castration-resistant and metastatic prostate cancer, providing a new treatment that would help the body fight its own cancer.